Endo Health to pay $39 million over fluoride labeling claims

NEW YORK (Reuters) - A generic drug maker owned by Endo International Plc has reached a $39 million settlement with the U.S. government and 47 states stemming from the unlawful labeling of multivitamins that contained fluoride.

http://ift.tt/1Yik5SR

from Reuters: Health News
via animenewspro